Ultrasound-enhanced transfection activity of HPMA-stabilized DNA polyplexes with prolonged plasma circulation

Qing Hui Zhou, Douglas L. Miller, Robert C. Carlisle, Leonard W. Seymour, David Oupicky

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Cancer gene therapy would greatly benefit from the possibility to deliver therapeutic genes via tumor-targeted systemic intravenous delivery. The main objective of this study was to determine biophysical, transfection, and pharmacokinetic properties of DNA complexes with reducible polycations that are reversibly stabilized by surface coating with multivalent HPMA copolymers. The specific goals were to evaluate compatibility of these polyplexes with extended plasma circulation, molecular targeting, and ultrasound-enhanced transfection activity. It was demonstrated that using polyplexes based on reducible polycations allows increasing transfection activity and preserving extended plasma circulation half-life observed for control polyplexes based on non-reducible polycations. In addition, the reversibly stabilized polyplexes were compatible with both molecular targeting using protein ligands as well as physical targeting using ultrasound-directed cavitation in vitro. As such, the described gene delivery vectors have the potential to permit efficient systemic delivery of therapeutic genes targeted by a local focused ultrasound treatment.

Original languageEnglish (US)
Pages (from-to)416-427
Number of pages12
JournalJournal of Controlled Release
Volume106
Issue number3
DOIs
StatePublished - Sep 2 2005

Fingerprint

hydroxypropyl methacrylate
Transfection
DNA
Genes
Neoplasm Genes
Protein Transport
Genetic Therapy
Half-Life
Therapeutics
Pharmacokinetics
Ligands
polycations
Neoplasms

Keywords

  • Gene delivery
  • In vivo
  • Polyplex
  • Transfection
  • Ultrasound

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Ultrasound-enhanced transfection activity of HPMA-stabilized DNA polyplexes with prolonged plasma circulation. / Zhou, Qing Hui; Miller, Douglas L.; Carlisle, Robert C.; Seymour, Leonard W.; Oupicky, David.

In: Journal of Controlled Release, Vol. 106, No. 3, 02.09.2005, p. 416-427.

Research output: Contribution to journalArticle

Zhou, Qing Hui ; Miller, Douglas L. ; Carlisle, Robert C. ; Seymour, Leonard W. ; Oupicky, David. / Ultrasound-enhanced transfection activity of HPMA-stabilized DNA polyplexes with prolonged plasma circulation. In: Journal of Controlled Release. 2005 ; Vol. 106, No. 3. pp. 416-427.
@article{a1ce5484cd8d4345970c11d72993b6e5,
title = "Ultrasound-enhanced transfection activity of HPMA-stabilized DNA polyplexes with prolonged plasma circulation",
abstract = "Cancer gene therapy would greatly benefit from the possibility to deliver therapeutic genes via tumor-targeted systemic intravenous delivery. The main objective of this study was to determine biophysical, transfection, and pharmacokinetic properties of DNA complexes with reducible polycations that are reversibly stabilized by surface coating with multivalent HPMA copolymers. The specific goals were to evaluate compatibility of these polyplexes with extended plasma circulation, molecular targeting, and ultrasound-enhanced transfection activity. It was demonstrated that using polyplexes based on reducible polycations allows increasing transfection activity and preserving extended plasma circulation half-life observed for control polyplexes based on non-reducible polycations. In addition, the reversibly stabilized polyplexes were compatible with both molecular targeting using protein ligands as well as physical targeting using ultrasound-directed cavitation in vitro. As such, the described gene delivery vectors have the potential to permit efficient systemic delivery of therapeutic genes targeted by a local focused ultrasound treatment.",
keywords = "Gene delivery, In vivo, Polyplex, Transfection, Ultrasound",
author = "Zhou, {Qing Hui} and Miller, {Douglas L.} and Carlisle, {Robert C.} and Seymour, {Leonard W.} and David Oupicky",
year = "2005",
month = "9",
day = "2",
doi = "10.1016/j.jconrel.2005.05.002",
language = "English (US)",
volume = "106",
pages = "416--427",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Ultrasound-enhanced transfection activity of HPMA-stabilized DNA polyplexes with prolonged plasma circulation

AU - Zhou, Qing Hui

AU - Miller, Douglas L.

AU - Carlisle, Robert C.

AU - Seymour, Leonard W.

AU - Oupicky, David

PY - 2005/9/2

Y1 - 2005/9/2

N2 - Cancer gene therapy would greatly benefit from the possibility to deliver therapeutic genes via tumor-targeted systemic intravenous delivery. The main objective of this study was to determine biophysical, transfection, and pharmacokinetic properties of DNA complexes with reducible polycations that are reversibly stabilized by surface coating with multivalent HPMA copolymers. The specific goals were to evaluate compatibility of these polyplexes with extended plasma circulation, molecular targeting, and ultrasound-enhanced transfection activity. It was demonstrated that using polyplexes based on reducible polycations allows increasing transfection activity and preserving extended plasma circulation half-life observed for control polyplexes based on non-reducible polycations. In addition, the reversibly stabilized polyplexes were compatible with both molecular targeting using protein ligands as well as physical targeting using ultrasound-directed cavitation in vitro. As such, the described gene delivery vectors have the potential to permit efficient systemic delivery of therapeutic genes targeted by a local focused ultrasound treatment.

AB - Cancer gene therapy would greatly benefit from the possibility to deliver therapeutic genes via tumor-targeted systemic intravenous delivery. The main objective of this study was to determine biophysical, transfection, and pharmacokinetic properties of DNA complexes with reducible polycations that are reversibly stabilized by surface coating with multivalent HPMA copolymers. The specific goals were to evaluate compatibility of these polyplexes with extended plasma circulation, molecular targeting, and ultrasound-enhanced transfection activity. It was demonstrated that using polyplexes based on reducible polycations allows increasing transfection activity and preserving extended plasma circulation half-life observed for control polyplexes based on non-reducible polycations. In addition, the reversibly stabilized polyplexes were compatible with both molecular targeting using protein ligands as well as physical targeting using ultrasound-directed cavitation in vitro. As such, the described gene delivery vectors have the potential to permit efficient systemic delivery of therapeutic genes targeted by a local focused ultrasound treatment.

KW - Gene delivery

KW - In vivo

KW - Polyplex

KW - Transfection

KW - Ultrasound

UR - http://www.scopus.com/inward/record.url?scp=23944462694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23944462694&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2005.05.002

DO - 10.1016/j.jconrel.2005.05.002

M3 - Article

C2 - 15967534

AN - SCOPUS:23944462694

VL - 106

SP - 416

EP - 427

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 3

ER -